| 标题 |
Gedatolisib after CDK4/6 inhibition in HR-positive/HER2-negative advanced breast cancer: pharmacology, phase III evidence, and therapeutic positioning |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)